| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ANKRD13B NCOA6 DDX17 SUPT20H SH3RF1 ANK3 HIPK1 RAPGEF4 BBS4 SUPT20HL2 CREBBP MIER1 JMJD1C KMT2C TSC22D1 ARID1B KMT2D TOB1 YAP1 TNRC6A SMARCC2 MAML2 CNOT2 YTHDF2 MED13 NUP153 | 3.12e-10 | 1160 | 107 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA6 DDX17 SUPT20H HIPK1 SUPT20HL2 CREBBP MIER1 JMJD1C KMT2C TSC22D1 ARID1B KMT2D TOB1 YAP1 SMARCC2 MAML2 CNOT2 MED13 | 1.07e-09 | 562 | 107 | 18 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | ANKRD13B SP1 NCOA6 DDX17 SUPT20H SH3RF1 ANK3 HIPK1 RAPGEF4 BBS4 SUPT20HL2 CREBBP MIER1 JMJD1C KMT2C TSC22D1 ARID1B KMT2D TOB1 YAP1 TNRC6A SMARCC2 MAML2 CNOT2 YTHDF2 MED13 NUP153 | 1.78e-09 | 1356 | 107 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | CDK9 MKRN4P NCOA6 DDX17 EP400 RBL2 CHD7 BARX2 CREBBP JMJD1C DDX11 ARID1B YAP1 SMARCC2 NFAT5 NONO NUP153 FOXC1 | 7.31e-08 | 739 | 107 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | CDK9 SP1 NCOA6 BBS4 CREBBP JMJD1C BPTF GTF2A1 YAP1 ATXN3 NFYA NFAT5 CNOT2 MED13 FOXC1 TBP KPNA2 | 5.11e-07 | 753 | 107 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | CDK9 SP1 SP2 RBL2 TRPS1 CHD7 BARX2 CREBBP HOXA2 BPTF GTF2A1 SALL2 MTF1 YAP1 SPZ1 FUBP1 ATXN3 NFYA NFYC NFAT5 POU2F3 TCFL5 FOXC1 TBP | 6.06e-07 | 1459 | 107 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA6 DDX17 CREBBP KMT2C TSC22D1 ARID1B KMT2D YAP1 SMARCC2 MAML2 MED13 | 6.97e-07 | 303 | 107 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | CDK9 SP1 SP2 CHD7 HOXA2 BPTF SALL2 MTF1 YAP1 SPZ1 FUBP1 NFYA NFYC NFAT5 POU2F3 TCFL5 FOXC1 TBP | 1.03e-04 | 1244 | 107 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.08e-04 | 140 | 107 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | CDK9 SP1 SP2 CHD7 HOXA2 BPTF SALL2 MTF1 YAP1 SPZ1 FUBP1 NFYA NFYC NFAT5 POU2F3 TCFL5 FOXC1 TBP | 1.35e-04 | 1271 | 107 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | histone modifying activity | 2.35e-04 | 229 | 107 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP1 NCOA6 BBS4 CREBBP JMJD1C GTF2A1 YAP1 MED13 FOXC1 TBP KPNA2 | 2.90e-04 | 582 | 107 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 3.98e-04 | 27 | 107 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.09e-04 | 417 | 107 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 4.21e-04 | 6 | 107 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 7.80e-04 | 8 | 107 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 7.93e-04 | 34 | 107 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 8.54e-04 | 560 | 107 | 10 | GO:0001228 | |
| GeneOntologyMolecularFunction | lncRNA binding | 8.64e-04 | 35 | 107 | 3 | GO:0106222 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 9.26e-04 | 566 | 107 | 10 | GO:0001216 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.18e-03 | 147 | 107 | 5 | GO:0042826 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.24e-03 | 10 | 107 | 2 | GO:0140999 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CDK9 SP1 NCOA6 DDX17 SUPT20H SUPT20HL2 CHD7 POGZ BARX2 CREBBP HOXA2 BPTF KMT2C GTF2A1 TSC22D1 PRDM10 KMT2D SALL2 MTF1 YAP1 SPZ1 NFYA NFYC MAML2 NFAT5 POU2F3 MED13 FOXC1 TBP | 5.83e-11 | 1390 | 107 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CDK9 EP400 EEF1AKMT3 RBL2 CHD7 POGZ CREBBP MIER1 JMJD1C DDX11 CDAN1 BPTF KMT2C GTF2A1 ARID1B KMT2D RCBTB1 SMARCC2 NFAT5 TBP | 1.82e-07 | 999 | 107 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.58e-07 | 14 | 107 | 4 | GO:0060213 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 7.23e-07 | 33 | 107 | 5 | GO:0000289 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.19e-06 | 16 | 107 | 4 | GO:0060211 | |
| GeneOntologyBiologicalProcess | chromatin organization | CDK9 EP400 EEF1AKMT3 RBL2 CHD7 CREBBP MIER1 JMJD1C DDX11 CDAN1 BPTF KMT2C ARID1B KMT2D RCBTB1 SMARCC2 NFAT5 | 3.52e-06 | 896 | 107 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | embryo development | SP1 SP2 NCOA6 SUPT20H HIPK1 BBS4 SUPT20HL2 CHD7 TNRC6C CUBN CREBBP HOXA2 BPTF KMT2D SALL2 YAP1 PDS5A CPLANE1 CNOT2 YTHDF2 FOXC1 | 1.32e-05 | 1437 | 107 | 21 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SP1 SUPT20H HIPK1 BBS4 SUPT20HL2 CHD7 TNRC6C CREBBP HOXA2 YAP1 PDS5A CPLANE1 YTHDF2 FOXC1 | 1.91e-05 | 713 | 107 | 14 | GO:0048598 |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.21e-05 | 65 | 107 | 5 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 3.02e-05 | 234 | 107 | 8 | GO:0006282 | |
| GeneOntologyBiologicalProcess | DNA damage response | CDK9 NCOA6 SUPT20H EP400 HIPK1 SUPT20HL2 POGZ CREBBP DDX11 ARID1B YAP1 ATXN3 SMARCC2 PDS5A NFAT5 NONO | 3.42e-05 | 959 | 107 | 16 | GO:0006974 |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.24e-05 | 16 | 107 | 3 | GO:1900153 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 1.00e-04 | 206 | 107 | 7 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 1.17e-04 | 211 | 107 | 7 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 1.17e-04 | 211 | 107 | 7 | GO:0061014 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | CDK9 EP400 EEF1AKMT3 CHD7 CREBBP MIER1 JMJD1C BPTF KMT2C ARID1B KMT2D SMARCC2 NFAT5 | 1.21e-04 | 741 | 107 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | DNA repair | CDK9 SUPT20H EP400 SUPT20HL2 POGZ CREBBP DDX11 ARID1B ATXN3 SMARCC2 PDS5A NONO | 1.36e-04 | 648 | 107 | 12 | GO:0006281 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.37e-04 | 95 | 107 | 5 | GO:2000781 | |
| GeneOntologyBiologicalProcess | viral penetration into host nucleus | 1.59e-04 | 4 | 107 | 2 | GO:0075732 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.60e-04 | 561 | 107 | 11 | GO:0048568 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SP1 SP2 NCOA6 BBS4 CHD7 CUBN HOXA2 BPTF KMT2D SALL2 YAP1 PDS5A CNOT2 FOXC1 | 2.45e-04 | 906 | 107 | 14 | GO:0043009 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CDK9 EP400 RBL2 PUM2 BBS4 EVI2B TSC22D2 CREBBP DDX11 ARID1B CEP250 CRNN SMARCC2 YTHDF2 HERC5 FOXC1 KCNH5 | 2.47e-04 | 1256 | 107 | 17 | GO:0051726 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | CDK9 SUPT20H EP400 PUM2 SUPT20HL2 CREBBP DDX11 ARID1B ATXN3 SMARCC2 MAP4K4 | 2.78e-04 | 598 | 107 | 11 | GO:0080135 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SP1 SP2 NCOA6 BBS4 CHD7 CUBN HOXA2 BPTF KMT2D SALL2 YAP1 PDS5A CNOT2 FOXC1 | 3.16e-04 | 929 | 107 | 14 | GO:0009792 |
| GeneOntologyBiologicalProcess | trophectodermal cell differentiation | 3.24e-04 | 26 | 107 | 3 | GO:0001829 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SP2 HIPK1 TRPS1 BARX2 CREBBP MIER1 HOXA2 BPTF ZNF469 SALL2 YAP1 SMARCC2 TCFL5 CNOT2 FOXC1 | 3.47e-04 | 1053 | 107 | 15 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.63e-04 | 27 | 107 | 3 | GO:1900151 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 4.07e-04 | 259 | 107 | 7 | GO:1903313 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 5.02e-04 | 443 | 107 | 9 | GO:1903311 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 6.28e-04 | 132 | 107 | 5 | GO:0000956 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | CDK9 SUPT20H EP400 SUPT20HL2 CREBBP DDX11 ARID1B SMARCC2 PDS5A KPNA2 | 7.05e-04 | 564 | 107 | 10 | GO:0051052 |
| GeneOntologyCellularComponent | chromatin | SP1 SP2 SUPT20H EP400 RBL2 TRPS1 SUPT20HL2 CHD7 POGZ BARX2 CREBBP JMJD1C DDX11 HOXA2 BPTF ARID1B PRDM10 NFYA NFYC SMARCC2 PDS5A NFAT5 POU2F3 TCFL5 FOXC1 TBP | 1.98e-08 | 1480 | 107 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | SP1 NCOA6 RBL2 BARX2 CREBBP MIER1 GTF2A1 PRDM10 YAP1 NFYA NFYC NFAT5 NONO POU2F3 TBP | 3.76e-07 | 596 | 107 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK9 NCOA6 EP400 CREBBP JMJD1C NUP54 DDX11 BPTF KMT2C GTF2A1 ARID1B KMT2D YAP1 NFYA NFYC SMARCC2 NONO MED13 NUP153 TBP | 1.98e-05 | 1377 | 107 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.77e-05 | 12 | 107 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 7.36e-05 | 269 | 107 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.15e-04 | 287 | 107 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | P-body | 1.80e-04 | 102 | 107 | 5 | GO:0000932 | |
| GeneOntologyCellularComponent | transcription factor TFIIA complex | 2.57e-04 | 5 | 107 | 2 | GO:0005672 | |
| GeneOntologyCellularComponent | CCAAT-binding factor complex | 3.84e-04 | 6 | 107 | 2 | GO:0016602 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 5.04e-04 | 272 | 107 | 7 | GO:0090575 | |
| GeneOntologyCellularComponent | host cell | 9.13e-04 | 9 | 107 | 2 | GO:0043657 | |
| GeneOntologyCellularComponent | bBAF complex | 1.14e-03 | 10 | 107 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.39e-03 | 94 | 107 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.50e-03 | 96 | 107 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.01e-03 | 104 | 107 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | npBAF complex | 2.27e-03 | 14 | 107 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 2.27e-03 | 14 | 107 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.39e-03 | 109 | 107 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | host cellular component | 2.61e-03 | 15 | 107 | 2 | GO:0018995 | |
| GeneOntologyCellularComponent | CCR4-NOT complex | 2.97e-03 | 16 | 107 | 2 | GO:0030014 | |
| GeneOntologyCellularComponent | nBAF complex | 2.97e-03 | 16 | 107 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 3.76e-03 | 18 | 107 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | transferase complex | CDK9 NCOA6 SUPT20H EP400 SUPT20HL2 ZSWIM6 CREBBP KMT2C GTF2A1 KMT2D MED13 TBP | 3.79e-03 | 963 | 107 | 12 | GO:1990234 |
| HumanPheno | Thick eyebrow | 3.43e-05 | 154 | 43 | 8 | HP:0000574 | |
| HumanPheno | Thin upper lip vermilion | TRPS1 TNRC6B POGZ CREBBP BPTF ARID1B KMT2D SMARCC2 NONO CNOT2 MED13 | 8.03e-05 | 339 | 43 | 11 | HP:0000219 |
| HumanPheno | Thin lips | TRPS1 TNRC6B POGZ CREBBP BPTF ARID1B KMT2D SMARCC2 NONO CNOT2 MED13 | 8.03e-05 | 339 | 43 | 11 | HP:0000213 |
| HumanPheno | Abnormality of the dentition | TRPS1 BBS4 CHD7 ZSWIM6 CREBBP JMJD1C POF1B SLC39A13 BPTF KMT2C ZNF469 ARID1B KMT2D SMARCC2 CPLANE1 NONO RSPO1 CNOT2 AMTN FOXC1 | 8.81e-05 | 1030 | 43 | 20 | HP:0000164 |
| HumanPheno | Severe expressive language delay | 1.17e-04 | 12 | 43 | 3 | HP:0006863 | |
| HumanPheno | Abnormality of dental eruption | TRPS1 CHD7 ZSWIM6 CREBBP SLC39A13 KMT2C ARID1B KMT2D SMARCC2 | 1.36e-04 | 240 | 43 | 9 | HP:0006292 |
| HumanPheno | Disinhibition | ANK3 RBL2 TNRC6B CHD7 POGZ ZSWIM6 CREBBP JMJD1C HOXA2 BPTF KMT2C ARID1B SMARCC2 NONO MED13 TBP KCNH5 | 1.50e-04 | 807 | 43 | 17 | HP:0000734 |
| HumanPheno | Inappropriate behavior | ANK3 RBL2 TNRC6B CHD7 POGZ ZSWIM6 CREBBP JMJD1C HOXA2 BPTF KMT2C ARID1B SMARCC2 NONO MED13 TBP KCNH5 | 1.50e-04 | 807 | 43 | 17 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | ANK3 RBL2 TNRC6B CHD7 POGZ ZSWIM6 CREBBP JMJD1C HOXA2 BPTF KMT2C ARID1B SMARCC2 NONO MED13 TBP KCNH5 | 1.50e-04 | 807 | 43 | 17 | HP:5200123 |
| HumanPheno | Social disinhibition | ANK3 RBL2 TNRC6B CHD7 POGZ ZSWIM6 CREBBP JMJD1C HOXA2 BPTF KMT2C ARID1B SMARCC2 NONO MED13 TBP KCNH5 | 1.50e-04 | 807 | 43 | 17 | HP:5200029 |
| MousePheno | abnormal prenatal growth/weight/body size | SP1 SP2 NCOA6 SUPT20H RBL2 SUPT20HL2 CHD7 POGZ CUBN CREBBP GPR107 NUP54 DDX11 CDAN1 BPTF INF2 MTF1 YAP1 FUBP1 SMARCC2 PDS5A CPLANE1 MAP4K4 FOXC1 TBP | 4.06e-06 | 1493 | 89 | 25 | MP:0004196 |
| MousePheno | embryonic lethality during organogenesis | SP1 SP2 NCOA6 EP400 RBL2 BBS4 CHD7 POGZ CUBN CREBBP GPR107 DDX11 BPTF KMT2D YAP1 TNRC6A MAP4K4 TBP | 8.23e-06 | 876 | 89 | 18 | MP:0006207 |
| MousePheno | prenatal lethality, incomplete penetrance | NCOA6 SUPT20H ANK3 STXBP5 BBS4 SUPT20HL2 CHD7 POGZ CREBBP KMT2C FUBP1 TNRC6A PDS5A CPLANE1 TBP KPNA2 | 1.71e-05 | 747 | 89 | 16 | MP:0011101 |
| MousePheno | prenatal growth retardation | SP2 NCOA6 SUPT20H SUPT20HL2 CHD7 CREBBP NUP54 DDX11 CDAN1 BPTF INF2 MTF1 FUBP1 PDS5A CPLANE1 MAP4K4 TBP | 2.88e-05 | 869 | 89 | 17 | MP:0010865 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | SP1 SP2 NCOA6 EP400 RBL2 CHD7 CUBN CREBBP GPR107 DDX11 BPTF KMT2D YAP1 TNRC6A MAP4K4 | 3.23e-05 | 700 | 89 | 15 | MP:0011098 |
| MousePheno | impaired somite development | 5.17e-05 | 104 | 89 | 6 | MP:0009768 | |
| MousePheno | abnormal embryonic tissue morphology | SP1 SP2 SUPT20H EP400 RBL2 HIPK1 BBS4 SUPT20HL2 CHD7 CUBN CREBBP NUP54 DDX11 HOXA2 BPTF SALL2 YAP1 MAP4K4 FOXC1 | 6.17e-05 | 1116 | 89 | 19 | MP:0002085 |
| MousePheno | abnormal neural tube morphology | SP2 SUPT20H EP400 RBL2 HIPK1 BBS4 SUPT20HL2 CHD7 CREBBP DDX11 HOXA2 SALL2 FOXC1 | 8.85e-05 | 591 | 89 | 13 | MP:0002151 |
| MousePheno | failure of intramembranous bone ossification | 1.20e-04 | 3 | 89 | 2 | MP:0008276 | |
| MousePheno | abnormal palatal shelf fusion at midline | 1.54e-04 | 80 | 89 | 5 | MP:0009887 | |
| MousePheno | abnormal prenatal body size | SP1 SP2 NCOA6 RBL2 POGZ CUBN CREBBP GPR107 DDX11 CDAN1 BPTF INF2 MTF1 YAP1 FUBP1 SMARCC2 PDS5A FOXC1 | 1.98e-04 | 1116 | 89 | 18 | MP:0010866 |
| Domain | Ago_hook | 1.93e-07 | 3 | 109 | 3 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.93e-07 | 3 | 109 | 3 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.93e-07 | 3 | 109 | 3 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 1.93e-07 | 3 | 109 | 3 | PF16608 | |
| Domain | SUZ | 7.70e-07 | 4 | 109 | 3 | IPR024771 | |
| Domain | SUZ | 7.70e-07 | 4 | 109 | 3 | PS51673 | |
| Domain | R3H | 1.58e-05 | 9 | 109 | 3 | SM00393 | |
| Domain | R3H | 3.08e-05 | 11 | 109 | 3 | PS51061 | |
| Domain | R3H | 3.08e-05 | 11 | 109 | 3 | PF01424 | |
| Domain | - | 3.08e-05 | 11 | 109 | 3 | 3.30.1370.50 | |
| Domain | R3H_dom | 3.08e-05 | 11 | 109 | 3 | IPR001374 | |
| Domain | Spt20 | 3.37e-05 | 2 | 109 | 2 | IPR021950 | |
| Domain | M_domain | 3.37e-05 | 2 | 109 | 2 | PF12938 | |
| Domain | GW182_M_dom | 3.37e-05 | 2 | 109 | 2 | IPR026805 | |
| Domain | Spt20 | 3.37e-05 | 2 | 109 | 2 | PF12090 | |
| Domain | SUZ | 1.01e-04 | 3 | 109 | 2 | PF12752 | |
| Domain | TSC-22_Dip_Bun | 2.01e-04 | 4 | 109 | 2 | IPR000580 | |
| Domain | TSC-22_Dip_Bun | 2.01e-04 | 4 | 109 | 2 | PD007152 | |
| Domain | TSC22 | 2.01e-04 | 4 | 109 | 2 | PF01166 | |
| Domain | TSC22 | 2.01e-04 | 4 | 109 | 2 | PS01289 | |
| Domain | RCC1 | 2.05e-04 | 20 | 109 | 3 | PF00415 | |
| Domain | SANT | 2.06e-04 | 50 | 109 | 4 | SM00717 | |
| Domain | RCC1_1 | 2.38e-04 | 21 | 109 | 3 | PS00625 | |
| Domain | RCC1_2 | 2.38e-04 | 21 | 109 | 3 | PS00626 | |
| Domain | RCC1_3 | 2.38e-04 | 21 | 109 | 3 | PS50012 | |
| Domain | SANT/Myb | 2.40e-04 | 52 | 109 | 4 | IPR001005 | |
| Domain | - | 2.75e-04 | 22 | 109 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 2.75e-04 | 22 | 109 | 3 | IPR000408 | |
| Domain | RCC1/BLIP-II | 3.15e-04 | 23 | 109 | 3 | IPR009091 | |
| Domain | FYrich_C | 3.34e-04 | 5 | 109 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.34e-04 | 5 | 109 | 2 | IPR003888 | |
| Domain | FYRC | 3.34e-04 | 5 | 109 | 2 | SM00542 | |
| Domain | FYRN | 3.34e-04 | 5 | 109 | 2 | SM00541 | |
| Domain | FYRN | 3.34e-04 | 5 | 109 | 2 | PF05964 | |
| Domain | FYRC | 3.34e-04 | 5 | 109 | 2 | PF05965 | |
| Domain | FYRC | 3.34e-04 | 5 | 109 | 2 | PS51543 | |
| Domain | FYRN | 3.34e-04 | 5 | 109 | 2 | PS51542 | |
| Domain | Homeodomain-like | 7.34e-04 | 332 | 109 | 8 | IPR009057 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.10e-03 | 35 | 109 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.41e-03 | 38 | 109 | 3 | PS00690 | |
| Domain | MYB_LIKE | 1.41e-03 | 38 | 109 | 3 | PS50090 | |
| Domain | Sp1_fam | 1.47e-03 | 10 | 109 | 2 | IPR030450 | |
| Domain | - | 1.93e-03 | 222 | 109 | 6 | 1.25.10.10 | |
| Domain | SET_dom | 3.10e-03 | 50 | 109 | 3 | IPR001214 | |
| Domain | SET | 3.10e-03 | 50 | 109 | 3 | PS50280 | |
| Domain | Post-SET_dom | 3.84e-03 | 16 | 109 | 2 | IPR003616 | |
| Domain | PostSET | 3.84e-03 | 16 | 109 | 2 | SM00508 | |
| Domain | POST_SET | 3.84e-03 | 16 | 109 | 2 | PS50868 | |
| Domain | UIM | 4.86e-03 | 18 | 109 | 2 | PF02809 | |
| Domain | ARM-like | 5.06e-03 | 270 | 109 | 6 | IPR011989 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 6.24e-08 | 149 | 72 | 9 | M27888 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 6.51e-08 | 42 | 72 | 6 | M27172 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 3.42e-07 | 55 | 72 | 6 | M27001 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.69e-06 | 220 | 72 | 9 | M27794 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.26e-06 | 118 | 72 | 7 | M27316 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 2.53e-06 | 6 | 72 | 3 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 2.53e-06 | 6 | 72 | 3 | M22047 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.12e-06 | 237 | 72 | 9 | M27786 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | CDK9 SP1 RBL2 HIPK1 TNRC6B TNRC6C CREBBP KMT2C GTF2A1 ARID1B KMT2D YAP1 TNRC6A ATXN3 NFYA NFYC SMARCC2 MAML2 CNOT2 MED13 TBP | 3.45e-06 | 1387 | 72 | 21 | M734 |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.41e-06 | 7 | 72 | 3 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.05e-05 | 9 | 72 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.05e-05 | 9 | 72 | 3 | M46436 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.17e-05 | 28 | 72 | 4 | M48253 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.32e-05 | 154 | 72 | 7 | M27832 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.35e-05 | 29 | 72 | 4 | M48076 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.49e-05 | 10 | 72 | 3 | M48013 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.88e-05 | 296 | 72 | 9 | M27869 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 2.02e-05 | 32 | 72 | 4 | M48012 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.12e-05 | 66 | 72 | 5 | M27938 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.58e-05 | 34 | 72 | 4 | M46422 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 2.72e-05 | 12 | 72 | 3 | M22006 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 2.91e-05 | 35 | 72 | 4 | M27190 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 3.52e-05 | 13 | 72 | 3 | M46434 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | SP1 NCOA6 EP400 TNRC6B TNRC6C CREBBP NUP54 DDX11 MTF1 TNRC6A NFYA NFYC MAP4K4 NUP153 | 6.41e-05 | 828 | 72 | 14 | M27827 |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 6.82e-05 | 16 | 72 | 3 | M27940 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 6.97e-05 | 137 | 72 | 6 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 8.25e-05 | 17 | 72 | 3 | M27788 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 8.61e-05 | 360 | 72 | 9 | M27267 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.11e-04 | 49 | 72 | 4 | MM14837 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 1.11e-04 | 49 | 72 | 4 | M48250 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.17e-04 | 19 | 72 | 3 | M48238 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.22e-04 | 95 | 72 | 5 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.29e-04 | 96 | 72 | 5 | M27792 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | CDK9 SP1 HIPK1 TNRC6B NUP54 GTF2A1 KMT2D YAP1 TNRC6A ATXN3 SMARCC2 MAML2 CNOT2 NUP153 TBP | 1.66e-04 | 1022 | 72 | 15 | MM15436 |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 2.15e-04 | 58 | 72 | 4 | M11980 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 2.97e-04 | 63 | 72 | 4 | M254 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.97e-04 | 63 | 72 | 4 | MM15613 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.05e-04 | 26 | 72 | 3 | M2499 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.51e-04 | 119 | 72 | 5 | M607 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 3.81e-04 | 6 | 72 | 2 | MM15083 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 3.94e-04 | 122 | 72 | 5 | M29689 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.66e-04 | 272 | 72 | 7 | M29619 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 5.01e-04 | 197 | 72 | 6 | M27188 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 5.22e-04 | 73 | 72 | 4 | MM15349 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 5.31e-04 | 7 | 72 | 2 | M6907 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 5.50e-04 | 74 | 72 | 4 | M48006 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 5.70e-04 | 32 | 72 | 3 | M39521 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 5.70e-04 | 32 | 72 | 3 | M27900 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 6.69e-04 | 137 | 72 | 5 | M145 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA6 ANK3 TNRC6B TNRC6C CREBBP HOXA2 KMT2C TSC22D1 ARID1B KMT2D YAP1 TNRC6A SMARCC2 MAML2 CNOT2 MED13 FOXC1 | 7.10e-04 | 1432 | 72 | 17 | M509 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.14e-04 | 139 | 72 | 5 | M715 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 7.74e-04 | 81 | 72 | 4 | M27647 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 8.48e-04 | 301 | 72 | 7 | MM15983 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 8.76e-04 | 37 | 72 | 3 | M29790 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 9.77e-04 | 149 | 72 | 5 | M4076 | |
| Pathway | REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES | 1.13e-03 | 10 | 72 | 2 | M801 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.15e-03 | 90 | 72 | 4 | M820 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 1.18e-03 | 41 | 72 | 3 | M29748 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.18e-03 | 41 | 72 | 3 | M29574 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.18e-03 | 41 | 72 | 3 | MM15200 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.27e-03 | 42 | 72 | 3 | M48018 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.37e-03 | 11 | 72 | 2 | M22033 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.37e-03 | 11 | 72 | 2 | M48021 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.38e-03 | 161 | 72 | 5 | M27871 | |
| Pathway | REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES | 1.64e-03 | 12 | 72 | 2 | M794 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.76e-03 | 47 | 72 | 3 | M29777 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.87e-03 | 254 | 72 | 6 | M27131 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.25e-03 | 14 | 72 | 2 | M27808 | |
| Pathway | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | 2.59e-03 | 15 | 72 | 2 | M603 | |
| Pathway | PID_SMAD2_3PATHWAY | 2.95e-03 | 16 | 72 | 2 | M228 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.95e-03 | 16 | 72 | 2 | M27121 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.00e-03 | 117 | 72 | 4 | M19248 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.33e-03 | 17 | 72 | 2 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.73e-03 | 18 | 72 | 2 | M26942 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 3.81e-03 | 125 | 72 | 4 | M27186 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.89e-03 | 62 | 72 | 3 | M27321 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 3.92e-03 | 126 | 72 | 4 | M45009 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 4.07e-03 | 63 | 72 | 3 | M27862 | |
| Pathway | REACTOME_GASTRULATION | 4.26e-03 | 129 | 72 | 4 | M46433 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.45e-03 | 65 | 72 | 3 | M39682 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.61e-03 | 20 | 72 | 2 | M27881 | |
| Pubmed | SP1 SP2 NCOA6 SUPT20H EP400 TRPS1 TNRC6B PUM2 R3HDM2 CHD7 POGZ TNRC6C FLG2 CREBBP MIER1 JMJD1C NUP54 BPTF KMT2C ARID1B KMT2D SALL2 YAP1 SPZ1 FUBP1 TNRC6A NFYA NFYC SMARCC2 PDS5A QSER1 R3HDM1 CNOT2 YTHDF2 FOXC1 TBP | 3.85e-23 | 1429 | 109 | 36 | 35140242 | |
| Pubmed | SP1 SUPT20H SH3RF1 ANK3 HIPK1 ARHGAP17 POGZ CREBBP NUP54 KMT2C GTF2A1 TSC22D1 CEP250 TNRC6A NFYA NFYC NAV3 CPLANE1 MAP4K4 NUP153 | 6.25e-17 | 486 | 109 | 20 | 20936779 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA6 TNRC6B PUM2 CREBBP JMJD1C NUP54 KMT2C ARID1B KMT2D MOGS FUBP1 TNRC6A QSER1 NONO CNOT2 YTHDF2 NUP153 | 8.33e-14 | 457 | 109 | 17 | 32344865 |
| Pubmed | 1.20e-13 | 83 | 109 | 10 | 28794006 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | CDK9 SP2 SUPT20H EP400 RBL2 TRPS1 CHD7 POGZ CREBBP JMJD1C HOXA2 KMT2C ARID1B KMT2D NFYC SMARCC2 | 1.45e-13 | 398 | 109 | 16 | 35016035 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 RBL2 HIPK1 TRPS1 POGZ CREBBP JMJD1C BPTF PRDM10 KMT2D SALL2 RCBTB1 NFYA NFYC SMARCC2 PDS5A QSER1 HERC5 FOXC1 TBP KPNA2 | 2.61e-13 | 857 | 109 | 21 | 25609649 |
| Pubmed | NCOA6 ANK3 EP400 MYCBP2 TNRC6B POGZ CREBBP JMJD1C BPTF KMT2C ARID1B KMT2D YAP1 QSER1 MAP4K4 NONO KPNA2 | 1.57e-12 | 549 | 109 | 17 | 38280479 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 EP400 TRPS1 POGZ JMJD1C BPTF ARID1B KMT2D YAP1 FUBP1 SMARCC2 PDS5A CNOT2 NUP153 | 4.03e-12 | 341 | 109 | 14 | 32971831 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 EP400 TRPS1 CHD7 POGZ FLG2 CREBBP NUP54 BPTF KMT2C ARID1B KMT2D SMARCC2 QSER1 | 5.93e-12 | 351 | 109 | 14 | 38297188 |
| Pubmed | NCOA6 EP400 TRPS1 CHD7 CREBBP JMJD1C ARID1B KMT2D YAP1 SMARCC2 QSER1 MED13 | 5.53e-11 | 268 | 109 | 12 | 33640491 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 SP2 NCOA6 DDX17 SUPT20H EP400 CHD7 POGZ SLFN5 MIER1 JMJD1C BPTF KMT2C KMT2D MOGS YAP1 PDS5A QSER1 NONO NUP153 FOXC1 KPNA2 | 8.32e-11 | 1294 | 109 | 22 | 30804502 |
| Pubmed | MKRN4P SP1 SP2 SH3RF1 TRPS1 EVI2A POGZ BARX2 CREBBP KMT2C GTF2A1 SALL2 MTF1 RCBTB1 NFAT5 POU2F3 CNOT2 | 8.57e-11 | 709 | 109 | 17 | 22988430 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.41e-10 | 167 | 109 | 10 | 20362541 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 NCOA6 EP400 MYCBP2 PUM2 CHD7 POGZ MIER1 BPTF KMT2D SSH1 YAP1 FUBP1 SMARCC2 MAP4K4 MED13 NUP153 | 3.28e-10 | 774 | 109 | 17 | 15302935 |
| Pubmed | MON2 EP400 STXBP5 HIPK1 TNRC6B PUM2 R3HDM2 POGZ ZSWIM6 TNRC6C NAV3 R3HDM1 NFAT5 | 5.41e-10 | 407 | 109 | 13 | 12693553 | |
| Pubmed | MON2 EP400 MYCBP2 TNRC6B PUM2 ARHGAP17 CHD7 JMJD1C ARID1B YAP1 TNRC6A QSER1 R3HDM1 MAP4K4 CNOT2 YTHDF2 | 1.25e-09 | 733 | 109 | 16 | 34672954 | |
| Pubmed | TNRC6B PUM2 R3HDM2 TNRC6C CREBBP JMJD1C GTF2A1 TNRC6A R3HDM1 | 1.35e-09 | 152 | 109 | 9 | 38360978 | |
| Pubmed | CDK9 NCOA6 DDX17 EP400 MYCBP2 CHD7 POGZ CREBBP JMJD1C BPTF KMT2C ARID1B KMT2D FUBP1 SMARCC2 PDS5A QSER1 NONO NUP153 | 1.54e-09 | 1103 | 109 | 19 | 34189442 | |
| Pubmed | 3.09e-09 | 19 | 109 | 5 | 21489275 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP1 SP2 TRPS1 BARX2 TSC22D2 MIER1 HOXA2 TSC22D1 KMT2D SALL2 MTF1 NFYA NFYC NFAT5 POU2F3 TCFL5 FOXC1 | 3.62e-09 | 908 | 109 | 17 | 19274049 |
| Pubmed | MKRN4P SP1 SP2 TRPS1 POGZ PKHD1L1 BPTF GTF2A1 TSC22D1 MTF1 NFYA NFYC NFAT5 POU2F3 CNOT2 TBP | 4.97e-09 | 808 | 109 | 16 | 20412781 | |
| Pubmed | 5.37e-09 | 78 | 109 | 7 | 28611094 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 NCOA6 ANK3 EP400 CHD7 TSC22D2 ZNF469 TOB1 YAP1 MAML2 NUP153 KPNA2 | 1.16e-08 | 430 | 109 | 12 | 35044719 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.11e-08 | 146 | 109 | 8 | 23892456 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.28e-08 | 283 | 109 | 10 | 30585729 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 31670606 | ||
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 2.99e-08 | 3 | 109 | 3 | 34108231 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 16880270 | ||
| Pubmed | MON2 CDK9 SP1 SUPT20H RBL2 ZSWIM6 TSC22D2 GPR107 KMT2C PRDM10 MOGS MTF1 MAML2 R3HDM1 MAP4K4 CNOT2 YTHDF2 MED13 KPNA2 | 3.02e-08 | 1327 | 109 | 19 | 32694731 | |
| Pubmed | 3.72e-08 | 157 | 109 | 8 | 30186101 | ||
| Pubmed | 4.12e-08 | 225 | 109 | 9 | 12168954 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 SUPT20H SH3RF1 EP400 HIPK1 ARHGAP17 CHD7 CREBBP DDX11 SALL2 YAP1 TNRC6A NONO | 4.30e-08 | 588 | 109 | 13 | 38580884 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CDK9 DDX17 SUPT20H EP400 MYCBP2 TNRC6B CHD7 POGZ FLG2 BPTF ARID1B MOGS SMARCC2 PDS5A MAP4K4 NONO KPNA2 | 4.69e-08 | 1082 | 109 | 17 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 DDX17 EP400 CHD7 POGZ JMJD1C BPTF ARID1B FUBP1 SMARCC2 PDS5A QSER1 NONO YTHDF2 NUP153 FOXC1 | 4.99e-08 | 954 | 109 | 16 | 36373674 |
| Pubmed | MON2 CDK9 SUPT20H EP400 TRPS1 TNRC6B POGZ CREBBP BPTF ZNF469 ARID1B SALL2 TNRC6A CRNN SMARCC2 FOXC1 TBP | 7.30e-08 | 1116 | 109 | 17 | 31753913 | |
| Pubmed | 8.92e-08 | 14 | 109 | 4 | 12482968 | ||
| Pubmed | 1.03e-07 | 119 | 109 | 7 | 23508102 | ||
| Pubmed | NCOA6 EP400 POGZ MIER1 GPR107 KMT2C ARID1B TNRC6A PCNX1 MAML2 MAP4K4 MED13 | 1.12e-07 | 529 | 109 | 12 | 14621295 | |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 1.20e-07 | 4 | 109 | 3 | 21063388 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 28398509 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10215616 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 18458062 | ||
| Pubmed | 1.21e-07 | 15 | 109 | 4 | 10567404 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 1.21e-07 | 15 | 109 | 4 | 21981923 | |
| Pubmed | SH3RF1 ANK3 TNRC6B JMJD1C GTF2A1 TNRC6A R3HDM1 MAP4K4 NUP153 | 1.56e-07 | 263 | 109 | 9 | 34702444 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 SUPT20H EP400 TNRC6B CREBBP JMJD1C SALL2 FUBP1 PDS5A NONO YTHDF2 | 1.62e-07 | 444 | 109 | 11 | 34795231 |
| Pubmed | EP400 CHD7 POF1B BPTF KMT2C KMT2D SSH1 TNRC6A SMARCC2 PDS5A KPNA2 | 2.79e-07 | 469 | 109 | 11 | 27634302 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | DDX17 EP400 TRPS1 CHD7 POGZ FLG2 PDS5A NFAT5 NONO YTHDF2 FOXC1 KPNA2 | 3.15e-07 | 583 | 109 | 12 | 29844126 |
| Pubmed | Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners. | 5.95e-07 | 6 | 109 | 3 | 12753906 | |
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 5.95e-07 | 6 | 109 | 3 | 17021013 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 7.18e-07 | 411 | 109 | 10 | 35182466 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TNRC6B CHD7 JMJD1C BPTF GTF2A1 RCBTB1 TNRC6A MAP4K4 CNOT2 MED13 KPNA2 | 1.04e-06 | 536 | 109 | 11 | 15840001 |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.04e-06 | 7 | 109 | 3 | 19470757 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 19556342 | ||
| Pubmed | TNRC6B CHD7 JMJD1C BPTF GTF2A1 RCBTB1 TNRC6A MAP4K4 CNOT2 MED13 KPNA2 | 1.07e-06 | 538 | 109 | 11 | 10512203 | |
| Pubmed | 1.30e-06 | 339 | 109 | 9 | 30415952 | ||
| Pubmed | 1.43e-06 | 61 | 109 | 5 | 20305087 | ||
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 1.66e-06 | 8 | 109 | 3 | 21447625 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.60e-06 | 123 | 109 | 6 | 26912792 | |
| Pubmed | 2.73e-06 | 124 | 109 | 6 | 20850016 | ||
| Pubmed | 3.48e-06 | 33 | 109 | 4 | 19336002 | ||
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 15601870 | ||
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 21984185 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 3.54e-06 | 10 | 109 | 3 | 16751102 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SP1 SP2 RBL2 TRPS1 BARX2 CREBBP HOXA2 GTF2A1 MTF1 SPZ1 NFYA CNOT2 TBP | 3.84e-06 | 877 | 109 | 13 | 20211142 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 MYCBP2 TNRC6B TNRC6C NUP54 MOGS RCBTB1 CEP250 R3HDM1 NUP153 FOXC1 KPNA2 | 4.54e-06 | 754 | 109 | 12 | 33060197 |
| Pubmed | 4.85e-06 | 11 | 109 | 3 | 10454579 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.35e-06 | 220 | 109 | 7 | 35785414 | |
| Pubmed | Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. | 6.45e-06 | 12 | 109 | 3 | 25438054 | |
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 35027733 | ||
| Pubmed | DDX17 RBL2 TRPS1 TNRC6B PUM2 POF1B TNRC6A NONO YTHDF2 NUP153 KPNA2 | 7.03e-06 | 655 | 109 | 11 | 35819319 | |
| Pubmed | 7.10e-06 | 418 | 109 | 9 | 34709266 | ||
| Pubmed | ANK3 BBS4 CHD7 CUBN MIER1 KMT2C ARID1B INF2 NFYC QSER1 CPLANE1 NFAT5 CNOT2 NUP153 | 7.69e-06 | 1084 | 109 | 14 | 11544199 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 8.18e-06 | 150 | 109 | 6 | 28242625 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 8.37e-06 | 13 | 109 | 3 | 17761849 | |
| Pubmed | 9.50e-06 | 234 | 109 | 7 | 36243803 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 CDK9 NCOA6 SH3RF1 EP400 MYCBP2 ARHGAP17 TNRC6C KMT2C KMT2D SSH1 INF2 PCNX1 MED13 | 9.54e-06 | 1105 | 109 | 14 | 35748872 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SP2 DDX17 TNRC6B MOGS QSER1 NONO CNOT2 YTHDF2 HERC5 FOXC1 KPNA2 | 9.71e-06 | 678 | 109 | 11 | 30209976 |
| Pubmed | TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells. | 9.73e-06 | 2 | 109 | 2 | 30082728 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 29791863 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 21705419 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17681538 | ||
| Pubmed | Structural characterisation of TNRC6A nuclear localisation signal in complex with importin-alpha. | 9.73e-06 | 2 | 109 | 2 | 28837617 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 31924266 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 35546636 | ||
| Pubmed | ATXN3 promotes prostate cancer progression by stabilizing YAP. | 9.73e-06 | 2 | 109 | 2 | 37349820 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 8595911 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28475860 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28967912 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 9041129 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 15117948 | ||
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 9.73e-06 | 2 | 109 | 2 | 27999180 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 36601880 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28483418 | ||
| Pubmed | O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y. | 9.73e-06 | 2 | 109 | 2 | 19302979 | |
| Pubmed | Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma. | 9.73e-06 | 2 | 109 | 2 | 32991341 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 11429405 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 18721470 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 36716535 | ||
| Interaction | CREBBP interactions | CDK9 SP1 NCOA6 DDX17 RBL2 HIPK1 CREBBP MIER1 ARID1B KMT2D MTF1 YAP1 ATXN3 NFYA SMARCC2 MAML2 NONO POU2F3 YTHDF2 HERC5 TBP KPNA2 | 7.81e-13 | 599 | 108 | 22 | int:CREBBP |
| Interaction | TBXT interactions | NCOA6 TRPS1 CHD7 POGZ CREBBP KMT2C ARID1B KMT2D YAP1 SMARCC2 QSER1 FOXC1 | 1.30e-12 | 116 | 108 | 12 | int:TBXT |
| Interaction | FEV interactions | SP2 NCOA6 SUPT20H EP400 TRPS1 CHD7 POGZ CREBBP KMT2C ARID1B KMT2D YAP1 QSER1 FOXC1 | 4.30e-12 | 203 | 108 | 14 | int:FEV |
| Interaction | HNF4A interactions | SP1 NCOA6 EP400 TRPS1 CHD7 POGZ CREBBP BPTF KMT2C ARID1B KMT2D SMARCC2 QSER1 FOXC1 TBP | 2.04e-11 | 275 | 108 | 15 | int:HNF4A |
| Interaction | NUP35 interactions | CDK9 NCOA6 TNRC6B PUM2 CREBBP JMJD1C NUP54 KMT2C ARID1B KMT2D FUBP1 TNRC6A QSER1 NONO CNOT2 YTHDF2 NUP153 | 1.08e-10 | 424 | 108 | 17 | int:NUP35 |
| Interaction | HNF1B interactions | EP400 TRPS1 CHD7 POGZ CREBBP BPTF KMT2C ARID1B KMT2D YAP1 QSER1 FOXC1 | 4.41e-10 | 190 | 108 | 12 | int:HNF1B |
| Interaction | SOX2 interactions | SP2 NCOA6 DDX17 EP400 TRPS1 PUM2 CHD7 POGZ SLFN5 MIER1 JMJD1C POF1B BPTF KMT2C ARID1B KMT2D SALL2 MOGS YAP1 FUBP1 TNRC6A ATXN3 NAV3 SMARCC2 QSER1 CPLANE1 YTHDF2 FOXC1 | 1.08e-09 | 1422 | 108 | 28 | int:SOX2 |
| Interaction | PAX6 interactions | NCOA6 EP400 TRPS1 CHD7 POGZ CREBBP BPTF KMT2C ARID1B KMT2D NFYC SMARCC2 QSER1 FOXC1 TBP | 1.10e-09 | 366 | 108 | 15 | int:PAX6 |
| Interaction | SMG7 interactions | NCOA6 TRPS1 TNRC6B R3HDM2 TNRC6C CREBBP JMJD1C ARID1B KMT2D SALL2 TNRC6A R3HDM1 CNOT2 YTHDF2 | 1.71e-09 | 319 | 108 | 14 | int:SMG7 |
| Interaction | EGR2 interactions | NCOA6 EP400 TRPS1 CHD7 POGZ FLG2 CREBBP KMT2C ARID1B KMT2D QSER1 | 2.01e-09 | 171 | 108 | 11 | int:EGR2 |
| Interaction | SOX9 interactions | 2.51e-09 | 97 | 108 | 9 | int:SOX9 | |
| Interaction | TEAD1 interactions | RBL2 TRPS1 CHD7 CREBBP BPTF KMT2C ARID1B KMT2D YAP1 FOXC1 TBP | 2.73e-09 | 176 | 108 | 11 | int:TEAD1 |
| Interaction | HDAC1 interactions | ANKRD13B SP1 DDX17 EP400 MYCBP2 RBL2 TRPS1 TNRC6B CREBBP MIER1 JMJD1C NUP54 BPTF KMT2D YAP1 CEP250 TNRC6A NFYA NFYC SMARCC2 NONO HERC5 TBP KPNA2 | 3.46e-09 | 1108 | 108 | 24 | int:HDAC1 |
| Interaction | SRF interactions | 3.83e-09 | 139 | 108 | 10 | int:SRF | |
| Interaction | WWTR1 interactions | NCOA6 ANK3 EP400 MYCBP2 TNRC6B POGZ CREBBP JMJD1C BPTF ARID1B KMT2D YAP1 QSER1 MAP4K4 KPNA2 | 7.56e-09 | 422 | 108 | 15 | int:WWTR1 |
| Interaction | KLF5 interactions | NCOA6 EP400 TRPS1 FLG2 CREBBP KMT2C ARID1B KMT2D YAP1 QSER1 TBP | 8.00e-09 | 195 | 108 | 11 | int:KLF5 |
| Interaction | SP7 interactions | NCOA6 EP400 TRPS1 CHD7 POGZ CREBBP KMT2C ARID1B KMT2D FUBP1 SMARCC2 QSER1 FOXC1 | 9.26e-09 | 304 | 108 | 13 | int:SP7 |
| Interaction | AR interactions | CDK9 SP1 NCOA6 DDX17 EP400 MYCBP2 TRPS1 CHD7 CREBBP JMJD1C KMT2C ARID1B KMT2D YAP1 FUBP1 SMARCC2 PDS5A QSER1 NONO MED13 TBP KPNA2 | 1.15e-08 | 992 | 108 | 22 | int:AR |
| Interaction | SOX7 interactions | 1.34e-08 | 82 | 108 | 8 | int:SOX7 | |
| Interaction | ETS1 interactions | 1.78e-08 | 121 | 108 | 9 | int:ETS1 | |
| Interaction | CNOT6 interactions | 1.95e-08 | 56 | 108 | 7 | int:CNOT6 | |
| Interaction | R3HDM2 interactions | 3.12e-08 | 129 | 108 | 9 | int:R3HDM2 | |
| Interaction | ERG interactions | NCOA6 HIPK1 TRPS1 CHD7 CREBBP KMT2C ARID1B KMT2D SMARCC2 QSER1 NONO | 3.21e-08 | 223 | 108 | 11 | int:ERG |
| Interaction | FOXI1 interactions | 3.35e-08 | 92 | 108 | 8 | int:FOXI1 | |
| Interaction | NFIX interactions | EP400 TRPS1 POGZ BPTF KMT2C ARID1B KMT2D SMARCC2 PDS5A QSER1 FOXC1 | 3.85e-08 | 227 | 108 | 11 | int:NFIX |
| Interaction | CNOT2 interactions | TNRC6B PUM2 R3HDM2 TNRC6C JMJD1C DDX11 TOB1 TNRC6A CNOT2 YTHDF2 | 4.11e-08 | 178 | 108 | 10 | int:CNOT2 |
| Interaction | SOX17 interactions | 4.32e-08 | 95 | 108 | 8 | int:SOX17 | |
| Interaction | CNOT9 interactions | CDK9 TNRC6B PUM2 R3HDM2 TNRC6C JMJD1C TOB1 TNRC6A MAP4K4 CNOT2 YTHDF2 | 4.60e-08 | 231 | 108 | 11 | int:CNOT9 |
| Interaction | EYA4 interactions | TNRC6B PUM2 R3HDM2 TNRC6C CREBBP JMJD1C POF1B GTF2A1 TNRC6A QSER1 R3HDM1 | 7.70e-08 | 243 | 108 | 11 | int:EYA4 |
| Interaction | MYOD1 interactions | SP1 EP400 TRPS1 CREBBP BPTF KMT2C ARID1B KMT2D SALL2 SMARCC2 | 9.26e-08 | 194 | 108 | 10 | int:MYOD1 |
| Interaction | ASF1A interactions | NCOA6 EP400 TRPS1 CHD7 POGZ CDAN1 ARID1B KMT2D SALL2 SMARCC2 QSER1 | 9.87e-08 | 249 | 108 | 11 | int:ASF1A |
| Interaction | MEN1 interactions | CDK9 NCOA6 DDX17 EP400 TRPS1 POGZ JMJD1C BPTF KMT2C ARID1B KMT2D YAP1 FUBP1 SMARCC2 PDS5A QSER1 NONO CNOT2 NUP153 FOXC1 KPNA2 | 1.07e-07 | 1029 | 108 | 21 | int:MEN1 |
| Interaction | FOS interactions | NCOA6 DDX17 EP400 RBL2 BARX2 CREBBP KMT2C ARID1B KMT2D SMARCC2 NFAT5 TBP | 1.14e-07 | 312 | 108 | 12 | int:FOS |
| Interaction | GATA2 interactions | NCOA6 TRPS1 CHD7 CREBBP KMT2C ARID1B KMT2D SMARCC2 QSER1 FOXC1 | 1.18e-07 | 199 | 108 | 10 | int:GATA2 |
| Interaction | CRX interactions | SP1 EP400 TRPS1 CHD7 POGZ CREBBP KMT2C ARID1B KMT2D NFYC QSER1 | 1.21e-07 | 254 | 108 | 11 | int:CRX |
| Interaction | HELZ interactions | EEF1AKMT3 TNRC6B PUM2 R3HDM2 TNRC6C CREBBP RCBTB1 TNRC6A R3HDM1 CNOT2 YTHDF2 | 1.36e-07 | 257 | 108 | 11 | int:HELZ |
| Interaction | SMAD2 interactions | CDK9 SP1 NCOA6 ANK3 CREBBP BPTF KMT2C ARID1B TOB1 YAP1 NFYC SMARCC2 NUP153 | 1.48e-07 | 385 | 108 | 13 | int:SMAD2 |
| Interaction | FHL2 interactions | SP1 SP2 SH3RF1 EP400 HIPK1 POGZ BARX2 CREBBP TOB1 NFYC QSER1 NFAT5 CNOT2 | 2.04e-07 | 396 | 108 | 13 | int:FHL2 |
| Interaction | TBPL2 interactions | 2.50e-07 | 11 | 108 | 4 | int:TBPL2 | |
| Interaction | NANOG interactions | SP1 EP400 PUM2 CHD7 POGZ JMJD1C CDAN1 BPTF KMT2C ARID1B SALL2 QSER1 NONO KPNA2 | 2.90e-07 | 481 | 108 | 14 | int:NANOG |
| Interaction | YAP1 interactions | NCOA6 DDX17 ANK3 TNRC6B POGZ FLG2 CREBBP JMJD1C BPTF KMT2C ARID1B KMT2D YAP1 FUBP1 ATXN3 SMARCC2 NFAT5 NONO POU2F3 FOXC1 KPNA2 | 3.02e-07 | 1095 | 108 | 21 | int:YAP1 |
| Interaction | PAX2 interactions | 3.65e-07 | 85 | 108 | 7 | int:PAX2 | |
| Interaction | PARP1 interactions | CDK9 SP1 NCOA6 EP400 MYCBP2 CHD7 POGZ FLG2 CREBBP HOXA2 BPTF MTF1 YAP1 FUBP1 ATXN3 NFYA NFYC SMARCC2 PDS5A MAP4K4 NONO FOXC1 TBP | 3.87e-07 | 1316 | 108 | 23 | int:PARP1 |
| Interaction | ELF1 interactions | 3.89e-07 | 126 | 108 | 8 | int:ELF1 | |
| Interaction | SMARCC2 interactions | SP1 DDX17 MYCBP2 CHD7 CREBBP ARID1B YAP1 FUBP1 SMARCC2 NUP153 FOXC1 KPNA2 | 4.28e-07 | 353 | 108 | 12 | int:SMARCC2 |
| Interaction | TLX1 interactions | 4.28e-07 | 175 | 108 | 9 | int:TLX1 | |
| Interaction | KLF15 interactions | SP2 EP400 TRPS1 POGZ CREBBP KMT2C KMT2D YAP1 NFYC QSER1 YTHDF2 | 4.54e-07 | 290 | 108 | 11 | int:KLF15 |
| Interaction | PAX9 interactions | 4.95e-07 | 130 | 108 | 8 | int:PAX9 | |
| Interaction | CEBPA interactions | CDK9 NCOA6 DDX17 EP400 MYCBP2 CHD7 POGZ CREBBP JMJD1C BPTF KMT2C ARID1B KMT2D MOGS FUBP1 NFYA SMARCC2 PDS5A QSER1 NONO NUP153 FOXC1 | 6.05e-07 | 1245 | 108 | 22 | int:CEBPA |
| Interaction | ALG13 interactions | 6.23e-07 | 183 | 108 | 9 | int:ALG13 | |
| Interaction | EIF4ENIF1 interactions | TNRC6B PUM2 R3HDM2 CREBBP DDX11 CEP250 TNRC6A R3HDM1 CNOT2 YTHDF2 KPNA2 | 6.35e-07 | 300 | 108 | 11 | int:EIF4ENIF1 |
| Interaction | CNOT6L interactions | 6.77e-07 | 93 | 108 | 7 | int:CNOT6L | |
| Interaction | GATA3 interactions | 7.47e-07 | 187 | 108 | 9 | int:GATA3 | |
| Interaction | SMAD3 interactions | CDK9 SP1 NCOA6 ANK3 CREBBP BPTF ARID1B TOB1 YAP1 NFYC SMARCC2 YTHDF2 NUP153 | 8.04e-07 | 447 | 108 | 13 | int:SMAD3 |
| Interaction | CNOT10 interactions | 9.19e-07 | 141 | 108 | 8 | int:CNOT10 | |
| Interaction | KMT2A interactions | CDK9 SP1 NCOA6 CREBBP KMT2C KMT2D YAP1 NFYC SMARCC2 NONO TBP | 9.94e-07 | 314 | 108 | 11 | int:KMT2A |
| Interaction | NCOA6 interactions | 1.14e-06 | 145 | 108 | 8 | int:NCOA6 | |
| Interaction | CPEB1 interactions | 1.20e-06 | 146 | 108 | 8 | int:CPEB1 | |
| Interaction | LHX1 interactions | 1.35e-06 | 103 | 108 | 7 | int:LHX1 | |
| Interaction | NFYA interactions | 1.54e-06 | 105 | 108 | 7 | int:NFYA | |
| Interaction | KLF8 interactions | SP1 SUPT20H EP400 TRPS1 CHD7 POGZ CREBBP BPTF KMT2D QSER1 YTHDF2 | 1.57e-06 | 329 | 108 | 11 | int:KLF8 |
| Interaction | MED23 interactions | NCOA6 SUPT20H EP400 TNRC6B PUM2 CREBBP YAP1 TNRC6A NFYC MED13 | 1.69e-06 | 266 | 108 | 10 | int:MED23 |
| Interaction | CPEB4 interactions | 1.97e-06 | 156 | 108 | 8 | int:CPEB4 | |
| Interaction | EN1 interactions | 2.11e-06 | 110 | 108 | 7 | int:EN1 | |
| Interaction | PAX8 interactions | 2.24e-06 | 111 | 108 | 7 | int:PAX8 | |
| Interaction | DUXB interactions | 2.25e-06 | 18 | 108 | 4 | int:DUXB | |
| Interaction | CNOT11 interactions | 2.38e-06 | 112 | 108 | 7 | int:CNOT11 | |
| Interaction | TBR1 interactions | 2.53e-06 | 113 | 108 | 7 | int:TBR1 | |
| Interaction | TNRC6A interactions | NCOA6 TNRC6B R3HDM2 TNRC6C KMT2C CEP250 TNRC6A CNOT2 YTHDF2 MED13 | 2.67e-06 | 280 | 108 | 10 | int:TNRC6A |
| Interaction | CNOT8 interactions | 2.84e-06 | 74 | 108 | 6 | int:CNOT8 | |
| Interaction | POU5F1 interactions | SP1 EP400 CHD7 CUBN JMJD1C CDAN1 BPTF ARID1B SALL2 NFYC SMARCC2 NONO TBP KPNA2 | 2.88e-06 | 584 | 108 | 14 | int:POU5F1 |
| Interaction | GPBP1 interactions | 3.07e-06 | 75 | 108 | 6 | int:GPBP1 | |
| Interaction | RNF43 interactions | DDX17 SH3RF1 ANK3 TNRC6B JMJD1C GTF2A1 TNRC6A R3HDM1 MAP4K4 NONO RSPO1 NUP153 | 3.12e-06 | 427 | 108 | 12 | int:RNF43 |
| Interaction | FASN interactions | MON2 CDK9 SP1 SUPT20H ZSWIM6 TSC22D2 GPR107 KMT2C PRDM10 MOGS MTF1 YAP1 ATXN3 MAML2 R3HDM1 MAP4K4 CNOT2 YTHDF2 MED13 | 3.35e-06 | 1062 | 108 | 19 | int:FASN |
| Interaction | POU3F2 interactions | 3.54e-06 | 20 | 108 | 4 | int:POU3F2 | |
| Interaction | TLX3 interactions | 3.76e-06 | 291 | 108 | 10 | int:TLX3 | |
| Interaction | SKP2 interactions | 4.37e-06 | 296 | 108 | 10 | int:SKP2 | |
| Interaction | FUBP3 interactions | CDK9 TNRC6B PUM2 R3HDM2 TNRC6C FUBP1 TNRC6A R3HDM1 CNOT2 YTHDF2 | 4.50e-06 | 297 | 108 | 10 | int:FUBP3 |
| Interaction | PAX7 interactions | 4.69e-06 | 124 | 108 | 7 | int:PAX7 | |
| Interaction | FOXJ2 interactions | 4.82e-06 | 81 | 108 | 6 | int:FOXJ2 | |
| Interaction | NFYC interactions | 5.04e-06 | 177 | 108 | 8 | int:NFYC | |
| Interaction | CNOT1 interactions | TNRC6B R3HDM2 TNRC6C GTF2A1 TOB1 YAP1 TNRC6A MAP4K4 CNOT2 YTHDF2 | 5.69e-06 | 305 | 108 | 10 | int:CNOT1 |
| Interaction | ZFP36 interactions | 5.94e-06 | 181 | 108 | 8 | int:ZFP36 | |
| Interaction | BAG2 interactions | SP1 NCOA6 EEF1AKMT3 ARHGAP17 SLFN5 CREBBP BPTF SALL2 YAP1 ATXN3 NFYC QSER1 R3HDM1 FOXC1 | 5.94e-06 | 622 | 108 | 14 | int:BAG2 |
| Interaction | SMG5 interactions | 5.96e-06 | 84 | 108 | 6 | int:SMG5 | |
| Interaction | PPARG interactions | SP1 NCOA6 DDX17 TRPS1 CREBBP JMJD1C POF1B KMT2C ARID1B KMT2D | 6.03e-06 | 307 | 108 | 10 | int:PPARG |
| Interaction | LHX2 interactions | 6.44e-06 | 183 | 108 | 8 | int:LHX2 | |
| Interaction | YTHDF2 interactions | TNRC6B PUM2 R3HDM2 TNRC6C CREBBP TNRC6A ATXN3 R3HDM1 CNOT2 YTHDF2 | 6.95e-06 | 312 | 108 | 10 | int:YTHDF2 |
| Interaction | SMARCA4 interactions | SP1 EP400 RBL2 CHD7 CREBBP BPTF ARID1B YAP1 SMARCC2 NONO FOXC1 KPNA2 | 6.96e-06 | 462 | 108 | 12 | int:SMARCA4 |
| Interaction | LHX3 interactions | 6.98e-06 | 185 | 108 | 8 | int:LHX3 | |
| Interaction | GSC interactions | 7.31e-06 | 87 | 108 | 6 | int:GSC | |
| Interaction | TERF2IP interactions | CDK9 NCOA6 ARPP21 EP400 CHD7 POGZ CREBBP BPTF SALL2 SMARCC2 PDS5A QSER1 FOXC1 | 8.11e-06 | 552 | 108 | 13 | int:TERF2IP |
| Interaction | JUN interactions | SP1 NCOA6 BARX2 CREBBP KMT2C YAP1 NFYA SMARCC2 PDS5A NFAT5 TBP KPNA2 | 8.28e-06 | 470 | 108 | 12 | int:JUN |
| Interaction | FAM120C interactions | 8.81e-06 | 191 | 108 | 8 | int:FAM120C | |
| Interaction | CREB1 interactions | 9.20e-06 | 254 | 108 | 9 | int:CREB1 | |
| Interaction | CNOT7 interactions | 1.04e-05 | 140 | 108 | 7 | int:CNOT7 | |
| Interaction | GTF2A2 interactions | 1.06e-05 | 26 | 108 | 4 | int:GTF2A2 | |
| Interaction | H2BC3 interactions | EP400 CHD7 POGZ CREBBP HOXA2 KMT2C KMT2D YAP1 SMARCC2 PDS5A NUP153 | 1.16e-05 | 406 | 108 | 11 | int:H2BC3 |
| Interaction | ESRRB interactions | 1.18e-05 | 262 | 108 | 9 | int:ESRRB | |
| Interaction | TPRX2 interactions | 1.24e-05 | 56 | 108 | 5 | int:TPRX2 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.76e-08 | 25 | 70 | 5 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.23e-05 | 53 | 70 | 4 | 532 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 3.06e-04 | 7 | 70 | 2 | 1350 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 5.23e-04 | 9 | 70 | 2 | 755 | |
| GeneFamily | DNA helicases | 1.94e-03 | 17 | 70 | 2 | 1167 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 4.18e-03 | 25 | 70 | 2 | 565 | |
| GeneFamily | PHD finger proteins | 5.13e-03 | 90 | 70 | 3 | 88 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DDX17 EP400 MYCBP2 RBL2 HIPK1 TRPS1 TNRC6B PUM2 EVI2A EVI2B DENND1C SLFN5 TNRC6C CREBBP MIER1 JMJD1C BPTF KMT2C KMT2D SSH1 PDS5A PCNX1 NFAT5 NONO CNOT2 MED13 NUP153 | 4.68e-11 | 1492 | 108 | 27 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.06e-08 | 180 | 108 | 9 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 PUM2 R3HDM2 CREBBP BPTF YAP1 FUBP1 NFYC PDS5A R3HDM1 CNOT2 MED13 NUP153 | 6.67e-08 | 466 | 108 | 13 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DDX17 SUPT20H MYCBP2 PUM2 R3HDM2 TSC22D2 CREBBP BPTF YAP1 FUBP1 NFYC NAV3 PDS5A R3HDM1 CNOT2 MED13 NUP153 | 7.95e-08 | 856 | 108 | 17 | M4500 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SP2 NCOA6 TSC22D2 CREBBP JMJD1C GPR107 TSC22D1 PRDM10 TOB1 MTF1 RCBTB1 ATXN3 NFYA PCNX1 NFAT5 | 1.43e-06 | 822 | 108 | 15 | M6782 |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 3.21e-06 | 289 | 108 | 9 | M13630 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | ANK3 RBL2 HIPK1 EVI2B R3HDM2 CREBBP TSC22D1 TOB1 NONO MED13 NUP153 KPNA2 | 4.03e-06 | 568 | 108 | 12 | M4023 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.34e-06 | 300 | 108 | 9 | M8702 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 5.00e-06 | 162 | 108 | 7 | M6847 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | DDX17 MYCBP2 RBL2 HIPK1 TMIGD2 TNRC6B EVI2A EVI2B DENND1C SLFN5 TNRC6C CREBBP BPTF SSH1 PCNX1 | 5.01e-06 | 911 | 108 | 15 | M40038 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 7.04e-06 | 240 | 108 | 8 | M39236 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 1.67e-05 | 195 | 108 | 7 | M4195 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MKRN4P SP2 RAPGEF4 PUM2 ARHGAP17 SLFN5 MINDY2 CREBBP KMT2C GTF2A1 TOB1 INF2 MED13 FOXC1 | 1.73e-05 | 888 | 108 | 14 | MM1018 |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 1.85e-05 | 198 | 108 | 7 | M7605 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 1.97e-05 | 200 | 108 | 7 | M4016 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 1.97e-05 | 200 | 108 | 7 | M9041 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 1.97e-05 | 200 | 108 | 7 | M9260 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | STXBP5 HIPK1 CHD7 TSC22D2 MIER1 JMJD1C NUP54 FUBP1 PDS5A MAP4K4 MED13 NUP153 | 2.43e-05 | 680 | 108 | 12 | M41089 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | SH3RF1 POGZ TSC22D2 JMJD1C SLC39A13 KMT2C TSC22D1 FAT2 PRDM10 YAP1 RCBTB1 FUBP1 MAML2 | 4.43e-05 | 843 | 108 | 13 | M2356 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SP2 RAPGEF4 PUM2 ARHGAP17 SLFN5 MINDY2 CREBBP KMT2C GTF2A1 TOB1 INF2 MED13 FOXC1 | 5.06e-05 | 854 | 108 | 13 | M1533 |
| Coexpression | BENPORATH_NANOG_TARGETS | SP2 DDX17 TSC22D2 MINDY2 NUP54 TSC22D1 ARID1B SALL2 INF2 YAP1 TNRC6A R3HDM1 NFAT5 TBP | 5.53e-05 | 988 | 108 | 14 | M6616 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 6.62e-05 | 166 | 108 | 6 | M344 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 6.62e-05 | 166 | 108 | 6 | M6826 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 7.20e-05 | 104 | 108 | 5 | M1318 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 7.80e-05 | 171 | 108 | 6 | M39234 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 8.24e-05 | 107 | 108 | 5 | MM1130 | |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 1.03e-04 | 180 | 108 | 6 | M8906 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MON2 SP1 DDX17 SUPT20H SH3RF1 RBL2 TNRC6B POGZ TSC22D1 ARID1B TOB1 ATXN3 | 1.25e-04 | 807 | 108 | 12 | M16651 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.35e-04 | 189 | 108 | 6 | M3112 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | MON2 NCOA6 SUPT20H RBL2 TRPS1 PUM2 BBS4 ARHGAP17 GPR107 TSC22D1 PRDM10 NFYC R3HDM1 NFAT5 KPNA2 | 1.38e-04 | 1215 | 108 | 15 | M41122 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP | 1.56e-04 | 194 | 108 | 6 | M4192 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 1.56e-04 | 194 | 108 | 6 | M7306 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_DN | 1.60e-04 | 195 | 108 | 6 | M5431 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN | 1.65e-04 | 196 | 108 | 6 | M4231 | |
| Coexpression | GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP | 1.69e-04 | 197 | 108 | 6 | M4167 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | CDK9 ARPP21 RBL2 BBS4 EVI2A EVI2B SLFN5 MINDY2 MIER1 FUBP1 R3HDM1 MAP4K4 POU2F3 CNOT2 NUP153 | 1.70e-04 | 1239 | 108 | 15 | M1743 |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP | 1.74e-04 | 198 | 108 | 6 | M8404 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP | 1.79e-04 | 199 | 108 | 6 | M9698 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 1.79e-04 | 199 | 108 | 6 | M5235 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP | 1.79e-04 | 199 | 108 | 6 | M6198 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.79e-04 | 199 | 108 | 6 | M3177 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 1.84e-04 | 200 | 108 | 6 | M5055 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M8997 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 1.84e-04 | 200 | 108 | 6 | M9923 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 1.84e-04 | 200 | 108 | 6 | M9952 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.84e-04 | 200 | 108 | 6 | M8497 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN | 1.84e-04 | 200 | 108 | 6 | M6774 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 1.84e-04 | 200 | 108 | 6 | M9273 | |
| Coexpression | GSE7852_TREG_VS_TCONV_DN | 1.84e-04 | 200 | 108 | 6 | M5752 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 1.89e-04 | 201 | 108 | 6 | M2200 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 2.27e-04 | 208 | 108 | 6 | M39233 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | CDK9 ARPP21 RBL2 BBS4 EVI2A EVI2B SLFN5 MINDY2 MIER1 FUBP1 R3HDM1 MAP4K4 POU2F3 CNOT2 NUP153 | 2.36e-04 | 1277 | 108 | 15 | MM1032 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MON2 RBL2 STXBP5 R3HDM2 CHD7 POGZ TSC22D2 CREBBP GPR107 FUBP1 NFYA MAP4K4 CNOT2 | 2.64e-04 | 1009 | 108 | 13 | M157 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 3.00e-04 | 141 | 108 | 5 | M39235 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_UP | 3.08e-04 | 78 | 108 | 4 | M1308 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | SUPT20H RBL2 BBS4 EVI2A EVI2B SUPT20HL2 MIER1 FUBP1 NFAT5 MAP4K4 POU2F3 CNOT2 NUP153 | 4.70e-04 | 1072 | 108 | 13 | MM1031 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 4.91e-04 | 157 | 108 | 5 | M7733 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP | 5.08e-04 | 242 | 108 | 6 | M904 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | MON2 ANK3 STXBP5 TRPS1 TNRC6B ZSWIM6 KMT2C ARID1B TNRC6A MAML2 | 6.66e-11 | 199 | 109 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.53e-10 | 188 | 109 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-09 | 192 | 109 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-08 | 186 | 109 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-08 | 186 | 109 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.50e-08 | 192 | 109 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.60e-08 | 193 | 109 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.43e-08 | 200 | 109 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.17e-07 | 156 | 109 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-07 | 183 | 109 | 7 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.77e-07 | 192 | 109 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.94e-07 | 193 | 109 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.11e-07 | 194 | 109 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.62e-06 | 191 | 109 | 6 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.62e-06 | 191 | 109 | 6 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.58e-06 | 195 | 109 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-06 | 198 | 109 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Severe / Disease, condition lineage and cell class | 9.63e-06 | 199 | 109 | 6 | 4fffd7b7355f8c56892e8e2d75f55f77b4e1bcc6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.91e-06 | 200 | 109 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.91e-06 | 200 | 109 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.09e-05 | 147 | 109 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 162 | 109 | 5 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.06e-05 | 163 | 109 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.06e-05 | 163 | 109 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 173 | 109 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-05 | 175 | 109 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.68e-05 | 178 | 109 | 5 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 8.30e-05 | 181 | 109 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.75e-05 | 183 | 109 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.97e-05 | 184 | 109 | 5 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.97e-05 | 184 | 109 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 185 | 109 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | E15.5-Epithelial-airway_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.44e-05 | 186 | 109 | 5 | bb2c7af3b1d8478c49a8626dbfd6c92c5e7adc4a | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.44e-05 | 186 | 109 | 5 | e083356f72995645f873ca0157d56bea5e942044 | |
| ToppCell | E15.5-Epithelial-airway_epithelial_cell-club_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.44e-05 | 186 | 109 | 5 | 86c809b99088d3d6c8f87785797c4beefdcddbe7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.44e-05 | 186 | 109 | 5 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.44e-05 | 186 | 109 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 189 | 109 | 5 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 189 | 109 | 5 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 189 | 109 | 5 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.02e-04 | 189 | 109 | 5 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.04e-04 | 190 | 109 | 5 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.12e-04 | 193 | 109 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 193 | 109 | 5 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 194 | 109 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-04 | 194 | 109 | 5 | 7c80fd2a70ee737d52738db6ad58577a15677fc4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 194 | 109 | 5 | 6385cf2a1529d2e225e407c33da959fccaaca3a4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 194 | 109 | 5 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-04 | 194 | 109 | 5 | 1154625adeafa354d8cc847e26b75f4f37e4c39f | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 194 | 109 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 194 | 109 | 5 | eaa5914009556af99eba80e1925db5c95d3a5b5d | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 1.15e-04 | 194 | 109 | 5 | 6aeedfdb2b526913937eea978ddcbab8be4e49a6 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 194 | 109 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-04 | 194 | 109 | 5 | a1fabd408a74c2649a69e57e8865b79fdfe9047f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-04 | 194 | 109 | 5 | 3844ef71804feef04948ff82fec4244e88fb63b2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-04 | 194 | 109 | 5 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-04 | 195 | 109 | 5 | 490c177f192deb5b7852d7123474476718670d5d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 195 | 109 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.18e-04 | 195 | 109 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 196 | 109 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.21e-04 | 196 | 109 | 5 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 197 | 109 | 5 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 197 | 109 | 5 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.24e-04 | 197 | 109 | 5 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-04 | 198 | 109 | 5 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 198 | 109 | 5 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-04 | 199 | 109 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.30e-04 | 199 | 109 | 5 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-04 | 199 | 109 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 200 | 109 | 5 | b7ab3f644e6002635771dccaa192a111b4e0ed5b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 200 | 109 | 5 | 2e01a35caeff5967a8b873c5122500d068dcf54c | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.33e-04 | 200 | 109 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.33e-04 | 200 | 109 | 5 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.44e-04 | 108 | 109 | 4 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.89e-04 | 116 | 109 | 4 | 9c92e714e210a2f29a9e228653d4c990ec643c72 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.79e-07 | 178 | 108 | 9 | 1112_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.90e-06 | 175 | 108 | 8 | 1058_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.98e-06 | 176 | 108 | 8 | 981_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.55e-06 | 182 | 108 | 8 | 1951_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.76e-06 | 184 | 108 | 8 | 2321_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.83e-05 | 172 | 108 | 7 | 1637_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.83e-05 | 172 | 108 | 7 | 1072_DN | |
| Drug | distamycin analog | 2.23e-05 | 2 | 108 | 2 | CID000371500 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.28e-05 | 178 | 108 | 7 | 3998_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.63e-05 | 182 | 108 | 7 | 3887_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.82e-05 | 184 | 108 | 7 | 6939_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.92e-05 | 185 | 108 | 7 | 1114_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.46e-05 | 190 | 108 | 7 | 4322_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.82e-05 | 193 | 108 | 7 | 6734_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; HL60; HG-U133A | 4.08e-05 | 195 | 108 | 7 | 1627_UP | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 4.49e-05 | 198 | 108 | 7 | 961_DN | |
| Drug | Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 4.64e-05 | 199 | 108 | 7 | 6337_DN | |
| Drug | 3-deazacytidine | 5.77e-05 | 206 | 108 | 7 | CID000001652 | |
| Disease | cortical thickness | MON2 ANKRD13B SP1 ZNF474 MYCBP2 TRPS1 TNRC6B CHD7 TSC22D2 MINDY2 JMJD1C ZNF469 ARID1B TNRC6A NAV3 QSER1 | 2.95e-06 | 1113 | 108 | 16 | EFO_0004840 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.33e-05 | 2 | 108 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | grip strength measurement | 4.55e-05 | 350 | 108 | 8 | EFO_0006941 | |
| Disease | gallstones | 4.94e-05 | 108 | 108 | 5 | EFO_0004210 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.44e-05 | 195 | 108 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 1.31e-04 | 27 | 108 | 3 | C0036920 | |
| Disease | waist-hip ratio | ARPP21 ANK3 MYCBP2 RBL2 TNRC6B BBS4 TSC22D2 JMJD1C BPTF TNRC6A NAV3 PCNX1 NFAT5 FOXC1 | 1.55e-04 | 1226 | 108 | 14 | EFO_0004343 |
| Disease | Neurodevelopmental Disorders | 3.86e-04 | 93 | 108 | 4 | C1535926 | |
| Disease | cortical surface area measurement | MON2 SP1 ANK3 ZNF474 MYCBP2 TNRC6B CHD7 TSC22D2 ZNF469 ARID1B TNRC6A NAV3 QSER1 MAP4K4 | 3.98e-04 | 1345 | 108 | 14 | EFO_0010736 |
| Disease | Squamous cell carcinoma of esophagus | 4.18e-04 | 95 | 108 | 4 | C0279626 | |
| Disease | Congenital small ears | 4.59e-04 | 41 | 108 | 3 | C0152423 | |
| Disease | diet measurement | NCOA6 SH3RF1 ANK3 TNRC6B ZSWIM6 MINDY2 JMJD1C ZNF469 ARID1B INF2 TNRC6A POU2F3 | 4.64e-04 | 1049 | 108 | 12 | EFO_0008111 |
| Disease | cancer (implicated_via_orthology) | 4.69e-04 | 268 | 108 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | dietary approaches to stop hypertension diet | 4.70e-04 | 9 | 108 | 2 | EFO_0803365 | |
| Disease | neuroimaging measurement | SP1 ANK3 ZNF474 TRPS1 TNRC6B CHD7 TSC22D2 JMJD1C ZNF469 TNRC6A NAV3 QSER1 | 5.49e-04 | 1069 | 108 | 12 | EFO_0004346 |
| Disease | Parkinson disease, late-onset | 5.86e-04 | 10 | 108 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 5.86e-04 | 10 | 108 | 2 | 168600 | |
| Disease | endometrial carcinoma | 8.04e-04 | 113 | 108 | 4 | EFO_1001512 | |
| Disease | metabolic syndrome | 8.62e-04 | 200 | 108 | 5 | EFO_0000195 | |
| Disease | Coffin-Siris syndrome | 1.01e-03 | 13 | 108 | 2 | C0265338 | |
| Disease | Connective Tissue Diseases | 1.01e-03 | 13 | 108 | 2 | C0009782 | |
| Disease | Lymphoma, Follicular, Grade 2 | 1.35e-03 | 15 | 108 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 1.35e-03 | 15 | 108 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 1.35e-03 | 15 | 108 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 1.35e-03 | 15 | 108 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 1.35e-03 | 15 | 108 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 1.35e-03 | 15 | 108 | 2 | C0079758 | |
| Disease | C-reactive protein measurement | NCOA6 ARPP21 ANK3 TRPS1 R3HDM2 CHD7 BPTF ZNF469 SMARCC2 QSER1 NFAT5 MAP4K4 | 1.55e-03 | 1206 | 108 | 12 | EFO_0004458 |
| Disease | Bladder Neoplasm | 1.78e-03 | 140 | 108 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.82e-03 | 141 | 108 | 4 | C0005684 | |
| Disease | keratoconus | 1.85e-03 | 66 | 108 | 3 | MONDO_0015486 | |
| Disease | age at onset, Parkinson disease | 1.95e-03 | 18 | 108 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.99e-03 | 355 | 108 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | triglyceride measurement, phospholipid measurement | 2.07e-03 | 146 | 108 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.10e-03 | 69 | 108 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.40e-03 | 152 | 108 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | urinary microalbumin measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0010967 | |
| Disease | Lymphoma, Follicular | 2.42e-03 | 20 | 108 | 2 | C0024301 | |
| Disease | Parkinson disease | 2.92e-03 | 22 | 108 | 2 | cv:C0030567 | |
| Disease | Renal glomerular disease | 3.19e-03 | 23 | 108 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.19e-03 | 23 | 108 | 2 | C4521256 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 3.50e-03 | 398 | 108 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.52e-03 | 276 | 108 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | basophil percentage of granulocytes | 3.54e-03 | 83 | 108 | 3 | EFO_0007995 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPQAAQLAGQRQSQQ | 556 | Q96L91 | |
| ASFQQPLGSNQALGQ | 456 | Q96RK4 | |
| QLNNGTPVTGQSQGQ | 486 | Q63HQ2 | |
| VQGTLTQIPNQQGHN | 186 | A6NCI8 | |
| NQQTILGSPASGIQN | 441 | Q92793 | |
| GTGQQNATSLSNPNP | 461 | Q92793 | |
| QIQGNVQANVPAGGQ | 111 | Q96AZ1 | |
| QQQQHPISNNNSLGG | 211 | Q8NFD5 | |
| GTLPNQQQSNQVFPS | 36 | Q6UX39 | |
| QNLFQQSLSGPQASV | 131 | Q8IV53 | |
| VAAQSQPQSNVQGQS | 2451 | Q12830 | |
| SQFSQGQEGLNQGNP | 211 | Q9P2D1 | |
| GAQPSQTSQGLQAQL | 836 | Q8IWY9 | |
| SQNVINNQQGTPVQS | 701 | Q9UBL0 | |
| QRQQVGTSSRNPGQQ | 436 | Q13434 | |
| QQPQSQSLVSGQPNS | 701 | Q15032 | |
| QSLVSGQPNSIGNQI | 706 | Q15032 | |
| GVQQPQNQGLLSSQR | 576 | Q9Y2K5 | |
| QLGNGTTNQGIAPVQ | 106 | Q8NDN9 | |
| SNINVNSELNPSTGN | 1166 | Q29RF7 | |
| GKPQNINDTSLNGNQ | 911 | Q2KHR3 | |
| QSQEPNVNPASAGNQ | 156 | Q5VW38 | |
| SQQAASQAQPGQQQV | 371 | Q8TB72 | |
| SQAQPGQQQVLRAGA | 376 | Q8TB72 | |
| TPNQGQQGQQAESLA | 396 | Q8TB72 | |
| AIQQISPGGQQQKQG | 806 | Q08999 | |
| QNGTLITQTLSQANP | 321 | Q86YJ7 | |
| QGQAGSQQRQPGSTV | 2276 | Q5D862 | |
| LQGSGQQNSQAGQRN | 641 | O95819 | |
| IPANGQQASSQNEGL | 41 | Q15233 | |
| QNIQQGSINSPSTQT | 3486 | Q8NEZ4 | |
| TTTQTNGQGDQQNPA | 561 | Q96AE4 | |
| GGTSAAQPLNLSQNQ | 1036 | Q86Z02 | |
| NSVGNGQASQTSQPN | 1531 | Q15652 | |
| QQQQQGDLSGQSSHP | 301 | P54252 | |
| NQGSTQGDPERNQLQ | 721 | Q8NCM2 | |
| GSPLSLQDGQQGQQS | 811 | Q96RV3 | |
| VHQGQVQENSPSGTQ | 1036 | Q9NYQ8 | |
| GQSTGNGAVQLPQQQ | 606 | Q8IVL0 | |
| TGRNQNENINTNPIT | 51 | P22794 | |
| ANSQNTTGNPLGQPT | 46 | P34910 | |
| QQAQQGLSPSHIQGS | 996 | Q9NQV6 | |
| TGNPATSNQAGNNNL | 406 | Q7Z3U7 | |
| GGNIKQNPNTQSLSQ | 456 | Q96FC9 | |
| NQLQNSPGSSQQTSG | 1431 | O94916 | |
| SVSQFLLSQTQPGQQ | 106 | Q9UKI9 | |
| QPDSSQQIQAITGNN | 206 | Q8WVV4 | |
| QQGSRGQNRPGVQTQ | 141 | Q9UBG3 | |
| AREQGQTQTQPGSGQ | 371 | Q9UBG3 | |
| QANLDQSQRGSSPQN | 361 | Q27J81 | |
| AQPQGQAQQAQSGTG | 206 | Q13952 | |
| PSGQGQGQFLIQQVT | 311 | Q13724 | |
| NLIPNGSSITVNQTN | 846 | Q9UII4 | |
| TSPLQENRNNQGTVN | 61 | P52292 | |
| NTQQQQQTTLGGLFS | 91 | Q7Z3B4 | |
| PNQSLQQAVGSQQFS | 996 | Q8IZL2 | |
| PGNSGAPQLQANQNV | 541 | Q14686 | |
| NSNPRTIQSGSNQLV | 2766 | O60494 | |
| GTIPSGQNSTGNVQN | 2141 | Q9H799 | |
| IGLNNSPVNGNSSCQ | 516 | Q12948 | |
| SQAQGQEQLEPSQGQ | 226 | Q9UMQ3 | |
| QPGNQAQAQAQLASL | 1171 | Q9BV73 | |
| LVTNGANVNAQSQNG | 126 | Q12955 | |
| QQLLQQGASPNAATT | 516 | Q12955 | |
| SQQFSGIGRSGQQPQ | 676 | Q92841 | |
| INRNSTGQQSQSGSP | 946 | Q49AJ0 | |
| GSQITQQSTNQSRNP | 346 | P50750 | |
| LQGQINSLFPQNGNV | 246 | Q13183 | |
| TVSGAGSFPQQQSQQ | 741 | Q9Y467 | |
| ASPGGEGQSLQQQQQ | 136 | Q96H72 | |
| NQNGVSSNGPGEILN | 401 | Q8N108 | |
| QPQTAVTAGQTQTQQ | 136 | P23511 | |
| LSQQQAPNGHNGDSQ | 256 | O43364 | |
| QQPLGSINLENQAQG | 31 | Q9NXJ0 | |
| AAAASTQAQQGQPAQ | 571 | Q8NBR6 | |
| PAGNRASNQGNSQPQ | 481 | Q8WZA2 | |
| NGTNGALVQSPSNQS | 21 | Q9HCJ0 | |
| NSNAGINLNLNPNAN | 91 | Q9HCJ0 | |
| PTQQANPGSTSQQQA | 746 | O75157 | |
| GRNNSQIASGQNQPQ | 591 | Q68EM7 | |
| QIASGQNQPQAAAGS | 596 | Q68EM7 | |
| LNGATSSPQNQEQIQ | 576 | Q14872 | |
| ANNNAGNPLVQQGGQ | 91 | Q7Z3K3 | |
| SLGQLAVQSPGQSNQ | 266 | Q7Z3K3 | |
| QQQQQQGTVGPLTSA | 246 | Q2MKA7 | |
| SSNGTNQTRGQIPQI | 1866 | O75592 | |
| GSQIANIGQQANIPT | 726 | Q15714 | |
| NIAQTPATQNGNLVQ | 856 | Q15714 | |
| NAGQQGQAPSLGQQQ | 436 | Q9UHV7 | |
| QQNQTSGGSLQAGQQ | 371 | P08047 | |
| NDNQIILQSPSSNGT | 106 | Q5T5J6 | |
| GSSSASQQQQQQHPP | 16 | Q5T5C0 | |
| EQIGQAGSTAGPQQQ | 1011 | Q8TAQ2 | |
| DLQSSQGGQQPRVQS | 111 | Q7Z6J0 | |
| FLQQGSSPQGQRSLQ | 51 | Q8WYL5 | |
| TGPQQQSHQLVSLQQ | 661 | P0C7V6 | |
| NNTPQLNRSLSQGTQ | 91 | Q9NZN8 | |
| QTILSLQQFQGPGAQ | 576 | Q15735 | |
| AQAQITATGQQQPQA | 246 | P52655 | |
| TATGQQQPQAQPAQT | 251 | P52655 | |
| QAQSGQANCQGLSPV | 166 | Q9UHF7 | |
| QQGPNLLQVRQGSQA | 26 | Q96BF3 | |
| QQQQQQGNKTGSRTG | 76 | Q5TF21 | |
| TSQQATQGTSGQAPQ | 106 | P20226 | |
| TGGQQQLTVQNVSGN | 456 | Q02086 | |
| PGGSLIFNTLQQQQQ | 626 | Q8NEM7 | |
| NPSNGDGFLEQQQQQ | 6 | Q5VX71 | |
| GDTINQSTLPSQQNR | 426 | P46937 | |
| NNNQVNGLSGNTTIP | 4131 | Q86WI1 | |
| ANQTPTFGQSQGASQ | 1321 | P49790 | |
| GLGLGSQQQPQQQQQ | 231 | P50616 | |
| GQGTANQLQPENGVS | 1966 | Q96JG9 | |
| NLTNALPQGANANQD | 491 | Q9HCJ5 | |
| NAQSSQAGPNQAQLV | 271 | Q6S9Z5 | |
| TLGNNGVGFQTQPNN | 281 | Q9BXG8 | |
| SSQANLGEQAQSGPQ | 381 | Q9UL49 | |
| NINVSNSLGPQAAQG | 146 | Q08AF3 | |
| SALTNQQPQNNGEVQ | 176 | Q8NDV7 | |
| ANNSPPVAQASVGQQ | 311 | Q9Y5A9 | |
| GANPNNAQVTGALLQ | 131 | Q9UPQ9 | |
| QQQQQQQHSLLSAPG | 3276 | O14686 | |
| QQQQGPGVQTNQALG | 3756 | O14686 |